Hypoglycaemia and kidney events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial

Diabetes Obes Metab. 2024 Aug;26(8):3478-3481. doi: 10.1111/dom.15687. Epub 2024 Jun 5.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Atherosclerosis* / complications
  • Atherosclerosis* / epidemiology
  • Diabetes Mellitus, Type 2* / blood
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetic Angiopathies / epidemiology
  • Diabetic Nephropathies* / blood
  • Diabetic Nephropathies* / complications
  • Female
  • Humans
  • Hypoglycemia* / chemically induced
  • Hypoglycemic Agents* / adverse effects
  • Hypoglycemic Agents* / therapeutic use
  • Male
  • Middle Aged

Substances

  • Hypoglycemic Agents